These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 11923217

  • 41. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
    Schick BP, Thornton RD.
    Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
    [Abstract] [Full Text] [Related]

  • 42. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
    Michaeli J, Lebedev YB, Richon VM, Chen ZX, Marks PA, Rifkind RA.
    Mol Cell Biol; 1990 Jul; 10(7):3535-40. PubMed ID: 1972544
    [Abstract] [Full Text] [Related]

  • 43. Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
    Pályi I.
    Pathol Res Pract; 1988 Dec; 184(1):11-7. PubMed ID: 3231568
    [Abstract] [Full Text] [Related]

  • 44. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z, Banks J, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [Abstract] [Full Text] [Related]

  • 45. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
    Weich N, Marks PA, Rifkind RA.
    Blood; 1990 Jul 15; 76(2):302-6. PubMed ID: 2369636
    [Abstract] [Full Text] [Related]

  • 46. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG, Ikeda K, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1986 Sep 15; 83(18):6849-53. PubMed ID: 3462732
    [Abstract] [Full Text] [Related]

  • 47. Maturation of murine erythroleukemia cells committed to differentiation requires protein kinase C.
    GuptaRoy B, Cohen CM.
    J Biol Chem; 1992 Aug 05; 267(22):15326-33. PubMed ID: 1386358
    [Abstract] [Full Text] [Related]

  • 48. Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.
    Melloni E, Pontremoli S, Viotti PL, Patrone M, Marks PA, Rifkind RA.
    J Biol Chem; 1989 Nov 05; 264(31):18414-8. PubMed ID: 2808382
    [Abstract] [Full Text] [Related]

  • 49. Proposal of a new PAF pharmacophoric map by the AM1 method.
    Rodrigues CR, de Alencastro RB, Barreiro EJ, Fraga CA.
    Eur J Pharm Sci; 1999 Aug 05; 8(4):309-15. PubMed ID: 10425381
    [Abstract] [Full Text] [Related]

  • 50. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
    Murate T, Kaneda T, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1984 Jun 05; 81(11):3394-8. PubMed ID: 6203120
    [Abstract] [Full Text] [Related]

  • 51. Induced differentiation of erythroleukemia cells by hexamethylene bisacetamide: a model for cytodifferentiation of transformed cells.
    Marks PA, Rifkind RA.
    Environ Health Perspect; 1989 Mar 05; 80():181-8. PubMed ID: 2647479
    [Abstract] [Full Text] [Related]

  • 52. Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
    Lau AH, Lai HK, Yeung BH, Leung SL, Tsang SY, Wong YH, Wise H.
    Prostaglandins Leukot Essent Fatty Acids; 2012 Mar 05; 86(3):119-26. PubMed ID: 22336225
    [Abstract] [Full Text] [Related]

  • 53. Pro-inflammatory response of alveolar macrophages induced by sulphite: studies with lucigenin-dependent chemiluminescence.
    Beck-Speier I, Dayal N, Maier KL.
    J Biolumin Chemilumin; 1998 Mar 05; 13(2):91-9. PubMed ID: 9633012
    [Abstract] [Full Text] [Related]

  • 54. Tumor promoter-mediated inhibition of cell differentiation: suppression of the expression of erythroid functions in murine erythroleukemia cells.
    Fibach E, Gambari R, Shaw PA, Maniatis G, Reuben RC, Sassa S, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1979 Apr 05; 76(4):1906-10. PubMed ID: 287029
    [Abstract] [Full Text] [Related]

  • 55. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
    Yamasaki H, Fibach E, Nudel U, Weinstein IB, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1977 Aug 05; 74(8):3451-5. PubMed ID: 269404
    [Abstract] [Full Text] [Related]

  • 56. BET bromodomain inhibition rescues erythropoietin differentiation of human erythroleukemia cell line UT7.
    Goupille O, Penglong T, Lefèvre C, Granger M, Kadri Z, Fucharoen S, Maouche-Chrétien L, Leboulch P, Chrétien S.
    Biochem Biophys Res Commun; 2012 Dec 07; 429(1-2):1-5. PubMed ID: 23137537
    [Abstract] [Full Text] [Related]

  • 57. Differential expression of Ran GTPase during HMBA-induced differentiation in murine erythroleukemia cells.
    Vanegas N, García-Sacristán A, López-Fernández LA, Párraga M, del Mazo J, Hernández P, Schvartzman JB, Krimer DB.
    Leuk Res; 2003 Jul 07; 27(7):607-15. PubMed ID: 12681360
    [Abstract] [Full Text] [Related]

  • 58. Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.
    Lohmeyer M, Workman P.
    Br J Cancer; 1995 Aug 07; 72(2):277-86. PubMed ID: 7640206
    [Abstract] [Full Text] [Related]

  • 59. Cellular-oncogene expression in Friend erythroleukemia cells: relationship to differentiation, commitment and TPA effects.
    Giroldi L, Hollstein M, Yamasaki H.
    Carcinogenesis; 1988 May 07; 9(5):817-21. PubMed ID: 3163274
    [Abstract] [Full Text] [Related]

  • 60. 1-Methylnicotinamide stimulates cell growth and inhibits hemoglobin synthesis in differentiating murine erythroleukemia cells.
    Kuykendall JR, Cox R, Kinder D.
    Toxicol In Vitro; 2007 Dec 07; 21(8):1656-62. PubMed ID: 17826027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.